As Chief Financial Officer, Lily and her team are responsible for financial operations, strategy, and accounting for Curana Health’s Medical Group and Health Plan operations.
Before joining Curana, Lily was a partner at New Enterprise Associates, where she oversaw healthcare services and technology investments. Her background also includes serving on the boards of Curana Health, Elion, Vori Health, Aetion, Belong Health, Everside Health, Strive Health, and TriValence.
Prior to NEA, Lily was a member of TPG’s North America Buyouts Group, where she focused on private equity transactions across health care services, biopharmaceuticals, and other industries.
Lily was named a Rising Star by the Venture Capital Journal and featured on Forbes’s 30 Under 30 list. She graduated summa cum laude from The Wharton School with a Bachelor of Science in business and the University of Pennsylvania with a Bachelor of Arts in biology.